- Home
- ONCY vs MGYR Comparison
ONCY vs MGYR Comparison
Compare ONCY & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- MGYR
- Stock Information
- Founded
- ONCY 1998
- MGYR 1922
- Country
- ONCY Canada
- MGYR United States
- Employees
- ONCY N/A
- MGYR N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- MGYR Savings Institutions
- Sector
- ONCY Health Care
- MGYR Finance
- Exchange
- ONCY Nasdaq
- MGYR Nasdaq
- Market Cap
- ONCY 89.7M
- MGYR 98.9M
- IPO Year
- ONCY 1999
- MGYR 2006
- Fundamental
- Price
- ONCY $1.05
- MGYR $17.00
- Analyst Decision
- ONCY Strong Buy
- MGYR
- Analyst Count
- ONCY 4
- MGYR 0
- Target Price
- ONCY $4.33
- MGYR N/A
- AVG Volume (30 Days)
- ONCY 1.5M
- MGYR 9.1K
- Earning Date
- ONCY 08-08-2025
- MGYR 07-24-2025
- Dividend Yield
- ONCY N/A
- MGYR 2.12%
- EPS Growth
- ONCY N/A
- MGYR 35.31
- EPS
- ONCY N/A
- MGYR 1.57
- Revenue
- ONCY N/A
- MGYR $35,533,000.00
- Revenue This Year
- ONCY N/A
- MGYR N/A
- Revenue Next Year
- ONCY N/A
- MGYR N/A
- P/E Ratio
- ONCY N/A
- MGYR $10.83
- Revenue Growth
- ONCY N/A
- MGYR 18.29
- 52 Week Low
- ONCY $0.33
- MGYR $11.96
- 52 Week High
- ONCY $1.53
- MGYR $19.04
- Technical
- Relative Strength Index (RSI)
- ONCY 53.00
- MGYR 57.61
- Support Level
- ONCY $1.18
- MGYR $16.50
- Resistance Level
- ONCY $1.35
- MGYR $17.20
- Average True Range (ATR)
- ONCY 0.13
- MGYR 0.29
- MACD
- ONCY -0.03
- MGYR -0.04
- Stochastic Oscillator
- ONCY 14.29
- MGYR 71.43
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.